Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean Claude Reubi

Showing results (51-60 of 185) with videos related to

Pageof 19
Sort By:
Journal of Medicinal Chemistry|August 3, 2011
N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and functionJudit Erchegyi, Renzo Cescato, Beatrice Waser, et al.
Bioconjugate Chemistry|March 17, 2005
Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistryMargret Schottelius, Friederike Rau, Jean Claude Reubi, et al.
Gastroenterology|July 20, 2010
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapyKjell E Oberg, Jean-Claude Reubi, Dik J Kwekkeboom, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2010
Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analogJean Claude Reubi, Judit Erchegyi, Renzo Cescato, et al.
Journal of Medicinal Chemistry|December 11, 2008
Highly potent 4-amino-indolo[2,3-c]azepin-3-one-containing somatostatin mimetics with a range of sst receptor selectivitiesDebby Feytens, Magali De Vlaeminck, Renzo Cescato, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
In vivo phosphorylation of the somatostatin 2A receptor in human tumorsQisheng Liu, Jean-Claude Reubi, Yining Wang, et al.
Peptides|December 21, 2019
GIP receptor: Expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studiesJean Claude Reubi, Daniel Fourmy, Arnau Cordomi, et al.
Journal of Medicinal Chemistry|April 15, 2005
N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivoMargret Schottelius, Jean Claude Reubi, Veronique Eltschinger, et al.
Bioconjugate Chemistry|September 19, 2002
Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydratesMargret Schottelius, Hans-Jürgen Wester, Jean Claude Reubi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2010
Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patientsJean Claude Reubi, Beatrice Waser, Renzo Cescato, et al.
Pageof 19

Showing results (51-60 of 185) with videos related to

Sort By:
Pageof 19
Journal of Medicinal Chemistry|August 3, 2011
N-imidazolebenzyl-histidine substitution in somatostatin and in its octapeptide analogue modulates receptor selectivity and functionJudit Erchegyi, Renzo Cescato, Beatrice Waser, et al.
Bioconjugate Chemistry|March 17, 2005
Modulation of pharmacokinetics of radioiodinated sugar-conjugated somatostatin analogues by variation of peptide net charge and carbohydration chemistryMargret Schottelius, Friederike Rau, Jean Claude Reubi, et al.
Gastroenterology|July 20, 2010
Role of somatostatins in gastroenteropancreatic neuroendocrine tumor development and therapyKjell E Oberg, Jean-Claude Reubi, Dik J Kwekkeboom, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 17, 2010
Switch from antagonist to agonist after addition of a DOTA chelator to a somatostatin analogJean Claude Reubi, Judit Erchegyi, Renzo Cescato, et al.
Journal of Medicinal Chemistry|December 11, 2008
Highly potent 4-amino-indolo[2,3-c]azepin-3-one-containing somatostatin mimetics with a range of sst receptor selectivitiesDebby Feytens, Magali De Vlaeminck, Renzo Cescato, et al.
The Journal of Clinical Endocrinology and Metabolism|December 13, 2003
In vivo phosphorylation of the somatostatin 2A receptor in human tumorsQisheng Liu, Jean-Claude Reubi, Yining Wang, et al.
Peptides|December 21, 2019
GIP receptor: Expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studiesJean Claude Reubi, Daniel Fourmy, Arnau Cordomi, et al.
Journal of Medicinal Chemistry|April 15, 2005
N-terminal sugar conjugation and C-terminal Thr-for-Thr(ol) exchange in radioiodinated Tyr3-octreotide: effect on cellular ligand trafficking in vitro and tumor accumulation in vivoMargret Schottelius, Jean Claude Reubi, Veronique Eltschinger, et al.
Bioconjugate Chemistry|September 19, 2002
Improvement of pharmacokinetics of radioiodinated Tyr(3)-octreotide by conjugation with carbohydratesMargret Schottelius, Hans-Jürgen Wester, Jean Claude Reubi, et al.
The Journal of Clinical Endocrinology and Metabolism|March 16, 2010
Internalized somatostatin receptor subtype 2 in neuroendocrine tumors of octreotide-treated patientsJean Claude Reubi, Beatrice Waser, Renzo Cescato, et al.
Pageof 19